MELANOMA OF UNKNOWN PRIMARY
Clinical trials for MELANOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new MELANOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for MELANOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major cancer trial tests new immune therapy to keep deadly skin cancer at bay
Disease control OngoingThis large study aimed to find the best treatment to prevent melanoma skin cancer from returning after it has been surgically removed. It compared a newer immune-boosting drug called ipilimumab against the standard treatment, interferon. Over 1,600 patients with high-risk melanom…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Boosting the immune system to fight skin cancer before surgery
Disease control OngoingThis study is testing if a new drug combination works better than a standard drug alone to shrink melanoma tumors before surgery. It involves 60 adults with stage III melanoma that can be surgically removed. The goal is to see if the combination helps the immune system attack the…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Trial aims to cut cancer treatment time in half using scans
Disease control OngoingThis study is testing if doctors can safely stop a standard immunotherapy treatment early for people with advanced melanoma. It uses special PET scans and sometimes a biopsy taken after one year of treatment to check if the cancer is under control. If the scan and biopsy show no …
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC